Common problems with antiretroviral therapy among three Swedish groups of HIV infected individuals

Amadou Jallow1, Sofia Kälvemark Sporrong, Lilian Walther-Jallow

  • 1Apoteket Källan, Box 64, 14501 Norsborg, Sweden. amadou.jallow@apoteket.se

Insights

Combination antiretroviral therapy (CART) presents unique challenges for different HIV-positive groups in Sweden, including social stigma and medication management issues. Addressing these specific patient needs is crucial for improving treatment adherence and outcomes.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pharmacology

Background:

  • HIV infection remains a significant global health concern.
  • Combination antiretroviral therapy (CART) is the cornerstone of HIV management.
  • Understanding patient-reported challenges is vital for optimizing treatment adherence and outcomes.

Purpose of the Study:

  • To identify and compare common problems faced by distinct HIV-positive populations undergoing CART in Sweden.
  • To investigate challenges experienced by homo- or bisexual individuals, former injecting drug users, and individuals of Sub-Saharan African origin.

Main Methods:

  • A problem detection study (PDS) was employed.
  • In-depth interviews informed questionnaire design.
  • 195 HIV-positive patients in major Swedish cities participated, yielding a 79% response rate.

Main Results:

  • Common issues across all groups included public stigma, concerns about disease progression or treatment failure, medication-related problems, and pharmacy visit difficulties.
  • Specific challenges varied: homo- or bisexual individuals faced drug-related issues (adverse effects, pill burden), former injecting drug users dealt with family conflicts and psychosocial burdens, and individuals of African origin feared medication exposure revealing their HIV status.

Conclusions:

  • Findings highlight the need for tailored pharmacy care for diverse HIV-positive patient groups.
  • General adherence strategies must be supplemented with group-specific interventions.
  • Further research on interventions promoting concordance and adherence is essential to prevent treatment failure and viral resistance.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...